In November, Buchanan flew to Miami to attend Wonderland, the largest psychedelic medicine business event. This was organised by Microdose, which is part of Conscious Fund, a Malta-based and psychedelic-focused VC firm that has partnered with Buchanan.
To put it succinctly, the event was incredible. It was truly wonderful to see so many people in real life gathered to discuss the future of psychedelics both as a business venture as well as a tool to ease the immense amount of suffering people are experiencing.
Speakers included Robin Carhart-Harris, PhD (Ralph Metzner Distinguished Professor of Neurology & Psychiatry, Director Psychedelics Division, Neuroscape at University of California, San Francisco), Mike Tyson (Advisor at Wesana Health), Matthew Johnson (Susan Hill Ward Professor of Psychedelics and Consciousness at Johns Hopkins University School of Medicine), Deborah Mash, PhD (CEO & Founder at DemeRx), Rick Doblin (Executive Director at MAPS), Dr. David Nutt (Chief Research Officer at Awakn Life Sciences), Dr. Ben Sessa (Chief Medical Officer at Awakn Life Sciences), Lynn Marie Morski (President at the Psychedelic Medicine Association) and William Leonard Pickard (Senior Advisor, Scientific Advisory Boards at William Leonard Pickard, JLS Fund LP & Psygen) (among others).
While the focus of the conference was the business of psychedelics, there were many conversations – both on stage and off – that focused on how psychedelics are creating a new paradigm for the way businesses are run, how health is defined and treated, how business leaders can create inclusive growth, and the best way to respect and integrate the indigenous communities that have been working with plant medicines for thousands of years.
We very much look forward to the 2023 edition of Wonderland and hope to see you there!